The Affordable Care Act and Diabetes Diagnosis and Care: Exploring the Potential Impacts

Economics and Policy in Diabetes (ES Huang and A Baig, Section Editors)
Part of the following topical collections:
  1. Topical Collection on Economics and Policy in Diabetes

Abstract

This article reviews available data on the implications of the Affordable Care Act (ACA) for the diagnosis and care of type 2 diabetes. We provide a general overview of the major issues for diabetes diagnosis and care, and describe the policies in the ACA that affect diabetes diagnosis and care. We also estimate that approximately 2.3 million of the 4.6 million people in the USA with undiagnosed diabetes aged 18–64 in 2009–2010 may have gained access to free preventive care under the ACA, which could increase diabetes detection. In addition, we note two factors that may limit the success of the ACA for improving access to diabetes care. First, many states with the highest diabetes prevalence have not expanded Medicaid eligibility, and second, primary care providers may not adequately meet the increase in Medicaid patients because federal funding to increase provider reimbursement for Medicaid visits recently expired. We close by discussing current gaps in the literature and future directions for research on the ACA’s impact on diabetes diagnosis, care, and health outcomes.

Keywords

Health care reform Diabetes Diagnosis Care Population health Health policy 

References

Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance

  1. 1.
    Blumenthal D, Abrams M, Nuzum R. The Affordable Care Act at 5 years. N Engl J Med. 2015;372(25):2451–8.CrossRefPubMedGoogle Scholar
  2. 2.
    Burge MR, Schade DS. Diabetes and the Affordable Care Act. Diabetes Technol Ther. 2014;16(7):399–413.CrossRefPubMedPubMedCentralGoogle Scholar
  3. 3.
    Hall MA, Lord R. Obamacare: what the Affordable Care Act means for patients and physicians. BMJ. 2014;349(oct22 7):g5376–g5376.Google Scholar
  4. 4.
    Ratner RE. Diabetes management in the age of national health reform. Diabetes Care. 2011;34(4):1054–7.Google Scholar
  5. 5.
    Holman RR, Paul SK, Bethel MA, Matthews DR, Neil HAW. 10-year follow-up of intensive glucose control in type 2 diabetes. N Engl J Med. 2008;359(15):1577–89.CrossRefPubMedGoogle Scholar
  6. 6.
    U.K. Prospective Diabetes Study. Are lower fasting plasma glucose levels at diagnosis of type 2 diabetes associated with improved outcomes? Diabetes Care. 2002;25(8):1410–7.Google Scholar
  7. 7.
    Laiteerapong N, Huang ES. Health care reform and chronic diseases: anticipating the health consequences. JAMA. 2010;304(8):899–900.CrossRefPubMedGoogle Scholar
  8. 8.
    Centers for Disease Control and Prevention. National Diabetes Statistics Report, 2014. [Internet]. Atlanta, GA; 2014 [cited 2015 Aug 28]. Available from: http://www.cdc.gov/diabetes/pubs/statsreport14/national-diabetes-report-web.pdf
  9. 9.
    Zhang X, Geiss LS, Cheng YJ, Beckles GL, Gregg EW, Kahn HS. The missed patient with diabetes. Diabetes Care. 2008;31(9):1748–53.CrossRefPubMedPubMedCentralGoogle Scholar
  10. 10.
    Harris MI, Eastman RC. Early detection of undiagnosed diabetes mellitus: a US perspective. Diabetes Metab Res Rev. 2000;16(4):230–6.CrossRefPubMedGoogle Scholar
  11. 11.
    Harris M, Klein R, Welborn T, Knuiman M. Onset of NIDDM occurs at least 4–7 years before clinical diagnosis. Diabetes Care. 1992;15(7):815–9.CrossRefPubMedGoogle Scholar
  12. 12.
    Hoerger TJ, Harris R, Hicks KA, Donahue K, Sorensen S, Engelgau M. Screening for type 2 diabetes mellitus: a cost-effectiveness analysis. Ann Intern Med. 2004;140(9):689–99.CrossRefPubMedGoogle Scholar
  13. 13.
    Kahn R, Alperin P, Eddy D, Borch-Johnsen K, Buse J, Feigelman J, et al. Age at initiation and frequency of screening to detect type 2 diabetes: a cost-effectiveness analysis. The Lancet. 2010;375(9723):1365–74.CrossRefGoogle Scholar
  14. 14.
    Ali MK, Bullard KM, Saaddine JB, Cowie CC, Imperatore G, Gregg EW. Achievement of goals in U.S. diabetes care, 1999–2010. N Engl J Med. 2013;368(17):1613–24.CrossRefPubMedGoogle Scholar
  15. 15.
    Goldman D, Joyce G, Escarce J. Pharmacy benefits and the use of drugs by the chronically ill. JAMA. 2004;291(19):2344–50.Google Scholar
  16. 16.
    Zhuo X, Zhang P, Kahn HS, Bardenheier BH, Li R, Gregg EW. Change in medical spending attributable to diabetes: national data from 1987 to 2011. Diabetes Care. 2015;38(4):581–7. doi:10.2337/dc14-1687.
  17. 17.
    Ayanian JZ, Weissman JS, Schneider EC, Ginsburg JA, Zaslavsky AM. Unmet health needs of uninsured adults in the United States. JAMA. 2000;284(16):2061–9.CrossRefPubMedGoogle Scholar
  18. 18.•
    Baicker K, Taubman SL, Allen HL, Bernstein M, Gruber JH, Newhouse JP, et al. The Oregon experiment—effects of Medicaid on clinical outcomes. N Engl J Med. 2013;368(18):1713–22. This is a randomized evaluation of the impact of Medicaid health insurance on diabetes detection and care.CrossRefPubMedPubMedCentralGoogle Scholar
  19. 19.
    Wolff JL, Starfield B, Anderson G. Prevalence, expenditures, and complications of multiple chronic conditions in the elderly. Arch Intern Med. 2002;162(20):2269–76.CrossRefPubMedGoogle Scholar
  20. 20.
    UK Prospective Diabetes Study Group. Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). Lancet. 1998;352(9131):854–65.CrossRefGoogle Scholar
  21. 21.
    Prospective UK. Diabetes Study Group. Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. BMJ. 1998;317(7160):703.CrossRefGoogle Scholar
  22. 22.
    Stratton IM, Adler AI, Neil HAW, Matthews DR, Manley SE, Cull CA, et al. Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study. BMJ. 2000;321:405–12.CrossRefPubMedPubMedCentralGoogle Scholar
  23. 23.•
    Burke A, Simmons A. Increased coverage of preventive services with zero cost sharing under the Affordable Care Act [Internet]. Department of Health and Human Services; 2014 Dec [cited 2015 Aug 25]. Available from: http://aspe.hhs.gov/sites/default/files/pdf/76901/ib_PreventiveServices.pdf. This study provides estimates of how many people in America gained access to preventive services such as diabetes screening without cost-sharing due to the ACA.
  24. 24.
    The Kaiser Family Foundation. Status of State Action on the Medicaid Expansion Decision [Internet]. [cited 2015 Aug 24]. Available from: http://kff.org/health-reform/state-indicator/state-activity-around-expanding-medicaid-under-the-affordable-care-act/
  25. 25.
    Gabel JR, Stromberg ST, Green M, Lischko A, Whitmore H. An early look at SHOP marketplaces: low premiums, adequate plan choice in many, but not all, states. Health Aff. 2015;34(5):732–40.CrossRefGoogle Scholar
  26. 26.
    Hackey RB, May EL. Measuring the performance of health insurance marketplaces. JAMA. 2015;314(7):667–8.CrossRefPubMedGoogle Scholar
  27. 27.
    Karaca-Mandic P, Fulton BD, Hollingshead A, Scheffler RM. States with stronger health insurance rate review authority experienced lower premiums n the individual market in 2010–13. Health Aff. 2015;34(8):1358–67.CrossRefGoogle Scholar
  28. 28.
    Kowalski AE. The early impact of the Affordable Care Act state-by-state. NBER Working Paper. 2014; Working Paper No. 20597.Google Scholar
  29. 29.
    Polsky D, Weiner J, Colameco C, Becker N. Deciphering the data: state-based marketplaces spent heavily to help enroll consumers. Leonard Davis Institute of Health Economics. 2014 [cited 2016 Feb 6]. Available from: http://ldihealtheconomist.com/media/state-based_marketplaces_spent_heavily_to_enroll_consumers.pdf.
  30. 30.
    Pollitz K, Tolbert J, Ma R. Survey of Health Insurance Marketplace Assister Programs: a first look at consumer assistance. Kaiser Family Foundation; 2014 Jul [cited 2016 Feb 6]. Available from: http://kff.org/health-reform/report/survey-of-health-insurance-marketplace-assister-programs/.
  31. 31.
    Sommers BD, Maylone B, Nguyen KH, Blendon RJ, Epstein AM. The impact of state policies on ACA applications and enrollment among low-income adults in Arkansas, Kentucky, and Texas. Health Aff. 2015;34(6):1010–8.CrossRefGoogle Scholar
  32. 32.
    Medicare Rights Center. The Affordable Care Act: closing the doughnut hole [Internet]. 2014 [cited 2015 Oct 24]. Available from: http://www.medicarerights.org/pdf/Closing-the-Doughnut-Hole-Chart.pdf
  33. 33.
    Heisler E. Physician Supply and the Patient Protection and Affordable Care Act [Internet]. Congressional Research Service; 2013 Jan [cited 2015 Aug 24]. Available from: http://op.bna.com/hl.nsf/id/myon-93zpre/$File/crsdoctor.pdf
  34. 34.
    Huang ES, Finegold K. Seven million Americans live in areas where demand for primary care may exceed supply by more than 10 percent. Health Aff. 2013;32(3):614–21.CrossRefGoogle Scholar
  35. 35.
    HRSA. Projecting the supply and demand for primary care practitioners through 2020. 2013 Nov [cited 2016 Feb 6]. Available at: http://bhpr.hrsa.gov/healthworkforce/supplydemand/usworkforce/primarycare/projectingprimarycare.pdf.
  36. 36.
    Hofer AN, Abraham JM, Moscovice I. Expansion of coverage under the Patient Protection and Affordable Care Act and primary care utilization. Milbank Q. 2011;89(1):69–89.CrossRefPubMedPubMedCentralGoogle Scholar
  37. 37.
    Petterson SM, Bazemore AW. Projecting US primary care physician workforce needs: 2010–2025. Ann Fam Med. 2012;10(6):503–9.CrossRefPubMedPubMedCentralGoogle Scholar
  38. 38.
    Williams E, Redhead CS. Public Health, Workforce, Quality and Related Provisions in the PPACA [Internet]. Congressional Research Service; 2010 Jun [cited 2015 Sep 30]. Report No.: 7–5700. Available from: https://www.aamc.org/download/130996/data/ph.pdf.pdf
  39. 39.
    Center for Medicare and Medicaid Services. ACO Shared Savings Program Quality Measures [Internet]. 2015 [cited 2015 Oct 24]. Available from: https://www.cms.gov/Medicare/Medicare-Fee-for-Service-Payment/sharedsavingsprogram/Downloads/ACO-Shared-Savings-Program-Quality-Measures.pdf
  40. 40.
    Taylor EF, Dale S, Peikes D, Brown R, Ghosh A, Crosson J, et al. Evaluation of the comprehensive primary care initiative: first annual report. Mathematica Policy Research; 2015 Jan [cited 2016 Feb 6]. Available from: https://innovation.cms.gov/files/reports/cpci-evalrpt1.pdf.
  41. 41.
    Centers for Disease Control and Prevention (CDC). National Center for Health Statistics (NCHS). National Health and Nutrition Examination Survey Data. U.S. Department of Health and Human Services, Centers for Disease Control and Prevention; 2009.Google Scholar
  42. 42.
    Carman KG, Eibner C, Paddock SM. Trends in health insurance enrollment, 2013–2015. Health Aff. 2015;34(6):1044–1048.Google Scholar
  43. 43.••
    Collins SR, Rasmussen PW, Doty MM, Beutel S. The rise in health care coverage and affordability since health reform took effect. Issue Brief (Commonw Fund). 2015;2(January):1–16. This study shows evidence of gains in insurance coverage and access to health care after the ACA.Google Scholar
  44. 44.••
    Long SK, Karpman M, Kenney GM, Zuckerman S, Wissoker D, Shartzer A, et al. Taking stock: gains in health insurance coverage under the ACA as of March 2015. Urban Institute; 2015. This study measures gains in health insurance coverage over the first two open enrollment periods.Google Scholar
  45. 45.••
    Sommers BD, Gunja MZ, Finegold K, Musco T. Changes in self-reported insurance coverage, access to care, and health under the Affordable Care Act. JAMA. 2015;314(4):366.  This study shows evidence of gains in health insurance coverage and access to care after the ACA.Google Scholar
  46. 46.
    Golberstein E, Gonzales G, Sommers BD. California’s early ACA expansion increased coverage and reduced out-of-pocket spending for the state’s low-income population. Health Aff. 2015;34(10):1688–94.CrossRefGoogle Scholar
  47. 47.
    Madden JM, Graves AJ, Zhang F, Adams AS, Briesacher BA, Ross-Degnan D, et al. Cost-related medication nonadherence and spending on basic needs following implementation of Medicare Part D. JAMA. 2008;299(16):1922–8.CrossRefPubMedPubMedCentralGoogle Scholar
  48. 48.
    Madden JM, Graves AJ, Ross-Degnan D, Briesacher BA, Soumerai SB. Cost-related medication nonadherence after implementation of Medicare Part D, 2006–2007. JAMA. 2009;302(16):1755–6.CrossRefPubMedPubMedCentralGoogle Scholar
  49. 49.
    Fung V, Mangione CM, Huang J, Turk N, Quiter ES, Schmittdiel JA, et al. Falling into the coverage gap: part D drug costs and adherence for Medicare Advantage prescription drug plan beneficiaries with diabetes. Health Serv Res. 2010;45(2):355–75.CrossRefPubMedPubMedCentralGoogle Scholar
  50. 50.
    Schmittdiel J, Ettner SL, Fung V, Huang J, Turk N, Quiter E, et al. The Medicare Part D coverage gap and diabetes beneficiaries. Am J Manag Care. 2009;15(3):189–93.PubMedPubMedCentralGoogle Scholar
  51. 51.
    Zhang Y, Donohue JM, Newhouse JP, Lave JR. The effects of the coverage gap on drug spending: a closer look at Medicare Part D. Health Aff. 2009;28(2):w317–25.CrossRefGoogle Scholar
  52. 52.
    Barnett AH. Insulin glargine in the treatment of type 1 and type 2 diabetes. Vasc Health Risk Manag. 2006;2(1):59.CrossRefPubMedPubMedCentralGoogle Scholar
  53. 53.
    Rosenstock J, Schwartz SL, Clark CM, Park GD, Donley DW, Edwards MB. Basal insulin therapy in type 2 diabetes: 28-week comparison of insulin glargine (HOE 901) and NPH insulin. Diabetes Care. 2001;24(4):631–6.CrossRefPubMedGoogle Scholar
  54. 54.
    Wang F, Carabino JM, Vergara CM. Insulin glargine: a systematic review of a long-acting insulin analogue. Clin Ther. 2003;25(6):1541–77. discussion 1539–40.CrossRefPubMedGoogle Scholar
  55. 55.
    Yki-Jarvinen H, Dressler A, Ziemen M. Less nocturnal hypoglycemia and better post-dinner glucose control with bedtime insulin glargine compared with bedtime NPH insulin during insulin combination therapy in type 2 diabetes. HOE 901/3002 Study Group. Diabetes Care. 2000;23(8):1130–6.CrossRefPubMedGoogle Scholar
  56. 56.•
    Polsky D, Richards M, Basseyn S, Wissoker D, Kenney GM, Zuckerman S, et al. Appointment availability after increases in Medicaid payments for primary care. N Engl J Med. 2015;372(6):537–45. This study shows a relationship between payment increases under the ACA and availability of appointments for Medicaid patients. This is important because these payment increases have since expired.Google Scholar
  57. 57.
    Tipirneni R, Rhodes KV, Hayward RA, Lichtenstein RL, Reamer EN, Davis MM, et al. Primary care appointment availability for new Medicaid patients increased after Medicaid expansion in Michigan. Health Aff. 2015;34(8):1399–406.CrossRefGoogle Scholar
  58. 58.
    McWilliams JM, Landon BE, Chernew ME, Zaslavsky AM. Changes in patients’ experiences in Medicare Accountable Care Organizations. N Engl J Med. 2014;371(18):1715–24.CrossRefPubMedPubMedCentralGoogle Scholar
  59. 59.
    McWilliams JM, Chernew ME, Landon BE, Schwartz AL. Performance differences in year 1 of pioneer accountable care organizations. N Engl J Med. 2015;372(20):1927–36.CrossRefPubMedPubMedCentralGoogle Scholar
  60. 60.
    Connolly V, Unwin N, Sherriff P, Bilous R, Kelly W. Diabetes prevalence and socioeconomic status: a population based study showing increased prevalence of type 2 diabetes mellitus in deprived areas. J Epidemiol Community Health. 2000;54(3):173–7.CrossRefPubMedPubMedCentralGoogle Scholar
  61. 61.
    Robbins JM, Vaccarino V, Zhang H, Kasl SV. Socioeconomic status and type 2 diabetes in African American and non-Hispanic white women and men: evidence from the Third National Health and Nutrition Examination Survey. Am J Public Health. 2001;91(1):76–83.CrossRefPubMedPubMedCentralGoogle Scholar
  62. 62.
    Centers for Disease Control and Prevention. U.S. Chronic disease indicators: diabetes [Internet]. 2015 [cited 2015 Aug 29]. Available from: https://chronicdata.cdc.gov/Chronic-Disease-Indicators/U-S-Chronic-Disease-Indicators-Diabetes/jx86-63vq/about
  63. 63.
    Kaufman HW, Chen Z, Fonseca VA, Mcphaul MJ. Surge in newly identified diabetes among Medicaid patients in 2014 within Medicaid expansion states under the Affordable Care Act. Diabetes Care. 2015;38(May):833–7.CrossRefPubMedGoogle Scholar
  64. 64.
    Snyder L, Paradise J, Rudowitz R. The ACA Primary Care Increase: State Plans for SFY 2015 [Internet]. 2014 [cited 2015 Aug 24]. Available from: http://kff.org/medicaid/perspective/the-aca-primary-care-increase-state-plans-for-sfy-2015/
  65. 65.
    Swartz K, Hall MA, Jost TS. How insurers competed in the Affordable Care Act’s first year. Issue Brief (Commonw Fund). 2015;18:1–16.Google Scholar
  66. 66.
    Kreuter M, McBride T, Caburnay C, Poor T, Thompson VLS, Alcaraz KI, et al. What can health communication science offer for ACA implementation? Five evidence-informed strategies for expanding Medicaid enrollment. Milbank Q. 2014;92(1):40–62.CrossRefPubMedPubMedCentralGoogle Scholar
  67. 67.
    Long SK, Kenney GM, Zuckerman S, Goin DE, Blavin F, Blumberg LJ, et al. The Health Reform Monitoring Survey: addressing data gaps to provide timely insights into the Affordable Care Act. Health Aff. 2014;33(1):161–7.CrossRefGoogle Scholar
  68. 68.
    Politi MC, Kaphingst KA, Kreuter M, Shacham E, Lovell MC, McBride T. Knowledge of health insurance terminology and details among the uninsured. Med Care Res Rev. 2014;71(1):85–98.CrossRefPubMedGoogle Scholar

Copyright information

© Springer Science+Business Media New York 2016

Authors and Affiliations

  1. 1.Harris School of Public PolicyUniversity of ChicagoChicagoUSA
  2. 2.Department of MedicineUniversity of ChicagoChicagoUSA

Personalised recommendations